Table of Content

1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Influenza Vaccine Market by Region
1.4.1 Global Influenza Vaccine Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Influenza Vaccine Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Influenza Vaccine Revenue by Players
2.1.1 Global Influenza Vaccine Revenue by Players (2019-2024)
2.1.2 Global Influenza Vaccine Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Influenza Vaccine Revenue in 2024
2.2 Global Influenza Vaccine Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Influenza Vaccine Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Hualan Bio
3.1.1 Hualan Bio Information
3.1.2 Hualan Bio Overview
3.1.3 Hualan Bio Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.1.4 Hualan Bio Related Developments
3.2 SANOFI
3.2.1 SANOFI Information
3.2.2 SANOFI Overview
3.2.3 SANOFI Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.2.4 SANOFI Related Developments
3.3 CCBIO
3.3.1 CCBIO Information
3.3.2 CCBIO Overview
3.3.3 CCBIO Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.3.4 CCBIO Related Developments
3.4 Changsheng Biological
3.4.1 Changsheng Biological Information
3.4.2 Changsheng Biological Overview
3.4.3 Changsheng Biological Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.4.4 Changsheng Biological Related Developments
3.5 SINOVAC
3.5.1 SINOVAC Information
3.5.2 SINOVAC Overview
3.5.3 SINOVAC Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.5.4 SINOVAC Related Developments
3.6 SIOBP
3.6.1 SIOBP Information
3.6.2 SIOBP Overview
3.6.3 SIOBP Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.6.4 SIOBP Related Developments
3.7 Aleph Biomedical
3.7.1 Aleph Biomedical Information
3.7.2 Aleph Biomedical Overview
3.7.3 Aleph Biomedical Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.7.4 Aleph Biomedical Related Developments
3.8 Adimmune
3.8.1 Adimmune Information
3.8.2 Adimmune Overview
3.8.3 Adimmune Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.8.4 Adimmune Related Developments
3.9 ZYAK
3.9.1 ZYAK Information
3.9.2 ZYAK Overview
3.9.3 ZYAK Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.9.4 ZYAK Related Developments
3.10 GSK
3.10.1 GSK Information
3.10.2 GSK Overview
3.10.3 GSK Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.10.4 GSK Related Developments
3.11 Aimei Hissen
3.11.1 Aimei Hissen Information
3.11.2 Aimei Hissen Overview
3.11.3 Aimei Hissen Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.11.4 Aimei Hissen Related Developments
3.12 Tianyuan Bio-pharma
3.12.1 Tianyuan Bio-pharma Information
3.12.2 Tianyuan Bio-pharma Overview
3.12.3 Tianyuan Bio-pharma Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.12.4 Tianyuan Bio-pharma Related Developments
3.13 Simcere Vaxtec
3.13.1 Simcere Vaxtec Information
3.13.2 Simcere Vaxtec Overview
3.13.3 Simcere Vaxtec Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.13.4 Simcere Vaxtec Related Developments
3.14 Tiantan Biological
3.14.1 Tiantan Biological Information
3.14.2 Tiantan Biological Overview
3.14.3 Tiantan Biological Influenza Vaccine Revenue and Gross Margin (2019-2024)
3.14.4 Tiantan Biological Related Developments
4 Global Influenza Vaccine Market Insights
4.1 Global Influenza Vaccine Market Revenue 2019-2024
4.2 Global Influenza Vaccine Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Influenza Vaccine Revenue by Type
5.2 Global Influenza Vaccine Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Influenza Vaccine Revenue by Application
6.2 Global Influenza Vaccine Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Influenza Vaccine Market Size by Type
7.1.1 Americas Influenza Vaccine Revenue by Type (2019-2024)
7.1.2 Americas Influenza Vaccine Revenue Share by Type (2019-2024)
7.2 Americas Influenza Vaccine Market Size by Application
7.2.1 Americas Influenza Vaccine Revenue by Application (2019-2024)
7.2.2 Americas Influenza Vaccine Revenue Share by Application (2019-2024)
7.3 Americas Influenza Vaccine Market Size by Country
7.3.1 Americas Influenza Vaccine Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Influenza Vaccine Market Size by Type
8.1.1 Europe Influenza Vaccine Revenue by Type (2019-2024)
8.1.2 Europe Influenza Vaccine Revenue Share by Type (2019-2024)
8.2 Europe Influenza Vaccine Market Size by Application
8.2.1 Europe Influenza Vaccine Revenue by Application (2019-2024)
8.2.2 Europe Influenza Vaccine Revenue Share by Application (2019-2024)
8.3 Europe Influenza Vaccine Market Size by Country
8.3.1 Europe Influenza Vaccine Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Influenza Vaccine Market Size by Type
9.1.1 Asia Pacific Influenza Vaccine Revenue by Type (2019-2024)
9.1.2 Asia Pacific Influenza Vaccine Revenue Share by Type (2019-2024)
9.2 Asia Pacific Influenza Vaccine Market Size by Application
9.2.1 Asia Pacific Influenza Vaccine Revenue by Application (2019-2024)
9.2.2 Asia Pacific Influenza Vaccine Revenue Share by Application (2019-2024)
9.3 Asia Pacific Influenza Vaccine Market Size by Region
9.3.1 Asia Pacific Influenza Vaccine Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Influenza Vaccine Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Influenza Vaccine Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Influenza Vaccine Market Size by Application
10.2.1 Middle East and Africa Influenza Vaccine Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Influenza Vaccine Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Influenza Vaccine Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Influenza Vaccine Industry Trends
11.2 Influenza Vaccine Market Drivers
11.3 Influenza Vaccine Market Challenges
11.4 Influenza Vaccine Market Restraints
12 Influenza Vaccine Forecasted Market Size by Type
12.1 Global Influenza Vaccine Forecasted Revenue by Type
12.2 Global Influenza Vaccine Forecasted Market Size Growth by Type 2024-2030
13 Influenza Vaccine Forecasted Market Size by Application
13.1 Global Influenza Vaccine Forecasted Revenue by Application
13.2 Global Influenza Vaccine Forecasted Market Size Growth by Application 2024-2030
14 Global Influenza Vaccine Market Forecasts
14.1 Global Influenza Vaccine Market Revenue Forecasts 2024-2030
14.2 Global Influenza Vaccine Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Influenza Vaccine Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Influenza Vaccine Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Influenza Vaccine Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Influenza Vaccine Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer